The Wall Street Transcript
The Wall Street Transcript - In-Depth Interviews for Investors
Healthcare >> CEO Interviews >> March 20, 2020

Interview with the Co-Founder and CEO: Nanobiotix (EPA:NANO)

Levy, Laurent
Laurent Levy is the Co-Founder of Nanobiotix and has been Chief Executive Officer since March 2003. He was appointed as Chairman of the executive board in 2004. He has extensive experience in sciences and techniques related to nanotechnologies. His research at the frontier of biotechnology and nanotechnologies has resulted in the development of a number of concrete applications, such as NBTXR3, which could open a new method for cancer treatment. Earlier, he was a consultant for Altran Technologies and worked in the development of the application of nanotechnologies with companies such as Sanofi S.A., Guerbet S.A. and Rhodia S.A., as well as for early-stage biotechnology companies. He also has been Chairman of the supervisory board of Valbiotis since March 2017, was a member of the Nanomedicine Translation Advisory Board from 2014 to 2019 and Vice Chairman of the executive board of the European Technology Platform on Nanomedicine from 2012 to 2019. He is the author of more than 35 international scientific publications and has applied for several patents. He holds a doctorate in physical chemistry from Pierre and Marie Curie University, or Universite Paris VI Pierre et Marie Curie, in Paris and from the CEA, or Commissariat a l’Energie Atomique et aux Energies Alternatives, and a DEA — advanced studies and diplomas — in physics of condensed matter from the UPVI-ESPCI, Paris, followed by a postdoctoral fellowship at the Institute for Lasers, Photonics and Biophotonics at the State University of New York, Buffalo.   Profile
Word count: 2,772

TWST: Could you tell me about the company?

Dr. Levy: Yes, of course. Nanobiotix was incorporated in 2003 on the idea that we could bring

Top Company Interviews

Microsoft Corporation
Intel Corporation
Pfizer, Inc.
General Electric Company
Walmart Inc.
International Business Machines Corporation
Citigroup Inc.
Exxon Mobil Corporation
Bank of America Corporation
Dell Inc.
Verizon Communications Inc.
Alphabet Inc

Register for a Free Account to gain greater access to The Wall Street Transcript right now

CEO INTERVIEWS
Interview with the CEO: Pasithea Therapeutics Corp. (NASDAQ:KTTA)
Interview with the CEO: BetterLife Pharma Inc. (OTCMKTS:BETRF)
Interview with the CEO: Cansortium Inc. (OTCMKTS:CNTMF)
SECTOR ROUNDTABLES
Natural Gas Weighs Heavy On E&P Near-Term Prospects
Roundtable Forum:optimism Despite Uncertainty In For-profit Education
Roundtable Forum:a Shift In Focus To Natural Gas From Oil
MONEY MANAGER INTERVIEWS
AI Opportunities Expand to Industrial, Utilities and Energy Sectors
India Fund Manager Expects Discretionary Spending to Grow
Inefficiency in Ex-US Markets Creates Opportunity to Buy at a Discount
ANALYST INTERVIEWS
Five Companies Dominate in Psychedelics-Based Drug Development
Cidara’s Long-Acting Antiviral Drug Could Be a Game Changer
Spotting Potential in the High-Risk, High Reward Neuroscience Space
Since 1963
© The Wall Street Transcript 2016, 2024
Terms and Conditions
Privacy Policy